PRESS RELEASE published on 05/23/2024 at 06:45, 2 years 5 months ago Galenica on track with sales growth Galenica Group reports 4.8% sales growth in the first four months of 2024, driven by positive pharmaceutical market development. Outlook for 2024 confirmed with sales growth between 3% and 5% Sales Growth Outlook 2024 Galenica Group Pharmaceutical Market
BRIEF published on 04/16/2024 at 18:10, 2 years 6 months ago Galenica Successfully Issues CHF 100 Million Bond Corporate Finance SIX Swiss Exchange Bond Issue Financial Stability Galenica AG
PRESS RELEASE published on 04/16/2024 at 18:05, 2 years 6 months ago Galenica successfully places a bond of over CHF 100 million Galenica successfully places a CHF 100 million fixed rate bond with a 7-year term and 1.65% annual coupon. The proceeds will be used for general corporate purposes, securing long-term financing Bond Long-term Financing Galenica AG CHF 100 Million Fixed Rate
BRIEF published on 04/10/2024 at 17:34, 2 years 6 months ago Shareholders of Galenica AG unanimously approve at the 7th Ordinary General Meeting Board Of Directors Dividend Annual Accounts General Assembly Galenica SA
PRESS RELEASE published on 04/10/2024 at 17:29, 2 years 6 months ago 7th Annual General Meeting: Shareholders approve all proposals Galenica Ltd.'s 7th Annual General Meeting sees approval of all proposals, including dividend of CHF 2.20 per share and re-election of Board of Directors members Board Of Directors Annual General Meeting Dividend Approval Galenica Ltd.
BRIEF published on 03/12/2024 at 06:50, 2 years 7 months ago Galenica announces sustained growth in 2023 and optimistic forecasts for 2024 Financial Results Sustainable Development Online Pharmacy Galenica Growth 2024
PRESS RELEASE published on 03/12/2024 at 06:45, 2 years 7 months ago Galenica continues to grow in the 2023 financial year Galenica Group achieves 4.4% sales growth in 2023, proposing stable dividend. Expects 3-5% sales growth in 2024, increased adjusted EBIT by 8-11% 2024 Outlook Sales Growth Dividend Proposal Galenica Group Adjusted EBIT Increase
Published on 11/06/2026 at 05:15, 5 hours 5 minutes ago Valeo and QNX Unveil A New Smart Camera Platform at CIIE, Secures Multiple Design Wins
Published on 11/06/2026 at 00:53, 9 hours 27 minutes ago Sekur Private Data Engages Darkstar Capital for Investor Awareness and Sekur Product Distribution
Published on 11/06/2026 at 00:45, 9 hours 35 minutes ago Gabriel Announces Closure of ICSID Annulment Proceedings
Published on 11/06/2026 at 10:15, 5 minutes ago Marco Fuchs Receives EY Entrepreneur Of The Year 2026 Award
Published on 11/06/2026 at 10:05, 15 minutes ago Smart City Expo 2026 closes after showing the real impact of urban solutions
Published on 11/06/2026 at 09:42, 37 minutes ago Silver for the Thorium Pioneer: Emerald Horizon Takes Second Place at “Innovator of the Year” 2026
Published on 11/06/2026 at 09:10, 1 hour 10 minutes ago Rentschler Biopharma Receives the Business Medal of the State of Baden-Wuerttemberg
Published on 11/05/2026 at 18:21, 15 hours 58 minutes ago Total number of voting rights and shares making up the share capital at October 31, 2026
Published on 11/05/2026 at 17:45, 16 hours 35 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 11/05/2026 at 17:29, 16 hours 51 minutes ago Notice of exercise of early redemption option of the subordinated note ISIN FR0010406082
Published on 11/05/2026 at 10:16, 1 day ago Growth acceleration confirmed in the third quarter of 2026 All businesses growing, revenue up +6,5%
